Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWI
2251
DELISTED
SolarWinds Corporation Common Stock
SWI
| $7.53M | ﹤0.01% |
733,727
+363,527
| +98% | +$3.31M |
|
2252
PUT
HSBC
HSBC
$352B
| $7.51M | ﹤0.01% |
189,600
+149,600
| +374% | +$5.58M |
|
2253
Copart
CPRT
$30.3B
| $7.49M | ﹤0.01% |
164,240
-1,271,898
| -89% | -$52.7M |
|
2254
CALL
ASML
ASML
$666B
| $7.46M | ﹤0.01% |
+10,300
| New | +$7M |
|
2255
Leslie's
LESL
$4.99M
| $7.45M | ﹤0.01% |
39,647
-18,089
| -31% | -$3.74M |
|
2256
CALL
Petrobras
PBR
$118B
| $7.44M | ﹤0.01% |
538,000
+96,200
| +22% | +$1.17M |
|
|
REVG
2257
DELISTED
REV Group
REVG
| $7.43M | ﹤0.01% |
560,305
+159,428
| +40% | +$1.82M |
|
2258
Iris Energy
IREN
$14.5B
| $7.42M | ﹤0.01% |
1,592,191
+1,321,625
| +488% | +$5.05M |
|
2259
Chewy
CHWY
$9.33B
| $7.41M | ﹤0.01% |
187,730
-447,653
| -70% | -$15.6M |
|
2260
PUT
MongoDB
MDB
$35.4B
| $7.4M | ﹤0.01% |
18,000
-1,900
| -10% | -$554K |
|
2261
Kenvue
KVUE
$36.9B
| $7.4M | ﹤0.01% |
+279,962
| New | +$7.3M |
|
|
TEN
2262
Tsakos Energy Navigation Ltd
TEN
$1.27B
| $7.39M | ﹤0.01% |
414,705
-522,238
| -56% | -$9.16M |
|
2263
DMC Global
BOOM
$144M
| $7.38M | ﹤0.01% |
415,341
+214,928
| +107% | +$3.89M |
|
2264
Sun Life Financial
SLF
$43.8B
| $7.37M | ﹤0.01% |
141,282
-789,355
| -85% | -$38.8M |
|
2265
DNOW Inc
DNOW
$2.94B
| $7.36M | ﹤0.01% |
710,278
-10,267
| -1% | -$103K |
|
2266
Arhaus
ARHS
$1.25B
| $7.35M | ﹤0.01% |
704,843
-933,547
| -57% | -$7.62M |
|
2267
Braskem
BAK
$654M
| $7.35M | ﹤0.01% |
630,646
+457,517
| +264% | +$4.33M |
|
2268
Cogent Biosciences
COGT
$6.44B
| $7.34M | ﹤0.01% |
620,016
+600,774
| +3,122% | +$6.89M |
|
|
DALS
2269
DELISTED
DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
| $7.33M | ﹤0.01% |
714,100
-40,000
| -5% | -$408K |
|
2270
Collegium Pharmaceutical
COLL
$820M
| $7.33M | ﹤0.01% |
340,922
-243,388
| -42% | -$5.53M |
|
|
SEDA
2271
DELISTED
SDCL EDGE Acquisition Corporation
SEDA
| $7.3M | ﹤0.01% |
700,000
| – | – |
|
2272
Atmos Energy
ATO
$28.3B
| $7.3M | ﹤0.01% |
62,765
-261,915
| -81% | -$30.3M |
|
|
SHYF
2273
DELISTED
The Shyft Group
SHYF
| $7.3M | ﹤0.01% |
331,009
-191,013
| -37% | -$4.49M |
|
|
CPAA
2274
DELISTED
Conyers Park III Acquisition Corp. Class A Common Stock
CPAA
| $7.3M | ﹤0.01% |
715,000
-20,000
| -3% | -$203K |
|
2275
Biomea Fusion
BMEA
$122M
| $7.29M | ﹤0.01% |
332,174
+45,143
| +16% | +$1.41M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.